CD14 genetics in sarcoidosis patients; who 's in control?

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 24, Issue 2, 2007, Pages 154-155

  Veltkamp, Marcel ^a   Grutters, Jan C ^a   Van Moorsel, Coline H M ^a   Rijkers, Ger T ^a   Ruven, Henk J T ^a   Drent, Marjolein ^b   Van Den Bosch, Jules M M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD14 promotor polymorphisms; Innate immunity; Sarcoidosis

Indexed keywords

CD14 ANTIGEN;

ALLELE; CROHN DISEASE; DNA POLYMORPHISM; ETHNIC GROUP; GREECE; HUMAN; LETTER; LUNG LAVAGE; PRIORITY JOURNAL; SARCOIDOSIS; TUBERCULOSIS;

ANTIGENS, CD14; GREECE; HUMANS; IMMUNITY, NATURAL; NETHERLANDS; POLYMORPHISM, GENETIC; SARCOIDOSIS;

EID: 41149130714     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Marks DJ, Harbord MW, MacAllister R, et al: Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006; 367: 668-78.
2. Ogus AC, Yoldas B, Ozdemir T, et al: The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J 2004; 2: 219-23.
3. Striz I, Zheng L, Wang YM, Pokorna H, Bauer PC, Costabel U: Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995; 151(2 Pt1): 544-7.
4. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD: A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20: 976-83.
5. Gazouli M, Koundourakis A, Ikonomopoulos J, et al: CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23:23-9.
6. Gazouli M, Mantzaris G, Kotsinas A, et al: Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005; 11: 681-5.